161 related articles for article (PubMed ID: 30039731)
1. Effects of Botulinum Toxin Treatment in Nonambulatory Children and Adolescents With Cerebral Palsy: Understanding Parents' Perspectives.
Nguyen L; Di Rezze B; Mesterman R; Rosenbaum P; Gorter JW
J Child Neurol; 2018 Oct; 33(11):724-733. PubMed ID: 30039731
[TBL] [Abstract][Full Text] [Related]
2. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
Nguyen L; Mesterman R; Gorter JW
BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
[TBL] [Abstract][Full Text] [Related]
3. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
4. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
5. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
Speth L; Janssen-Potten Y; Leffers P; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles JS
Eur J Paediatr Neurol; 2015 May; 19(3):337-48. PubMed ID: 25661064
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
[TBL] [Abstract][Full Text] [Related]
8. Protocol for The Toxin Study: Understanding clinical and patient reported response of children and young people with cerebral palsy to intramuscular lower limb Botulinum neurotoxin-A injections, exploring all domains of the ICF. A pragmatic longitudinal observational study using a prospective one-group repeated measures design.
Katchburian LR; Oulton K; Main E; Morris C; Carr LJ
BMJ Open; 2021 Apr; 11(4):e049542. PubMed ID: 33883158
[TBL] [Abstract][Full Text] [Related]
9. Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy.
Edwards P; Sakzewski L; Copeland L; Gascoigne-Pees L; McLennan K; Thorley M; Kentish M; Ware R; Boyd RN
Pediatrics; 2015 Nov; 136(5):895-904. PubMed ID: 26482662
[TBL] [Abstract][Full Text] [Related]
10. Activities and participation of children with cerebral palsy: parent perspectives.
Mei C; Reilly S; Reddihough D; Mensah F; Green J; Pennington L; Morgan AT
Disabil Rehabil; 2015; 37(23):2164-73. PubMed ID: 25586796
[TBL] [Abstract][Full Text] [Related]
11. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity activities in unilateral Cerebral Palsy: a clinical trial.
Speth L; Janssen-Potten Y; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles H
BMC Neurol; 2015 Aug; 15():143. PubMed ID: 26286662
[TBL] [Abstract][Full Text] [Related]
12. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
14. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
15. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
16. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review.
Kahraman A; Seyhan K; Değer Ü; Kutlutürk S; Mutlu A
Dev Med Child Neurol; 2016 Sep; 58(9):910-7. PubMed ID: 27103334
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
[TBL] [Abstract][Full Text] [Related]
18. The influence of physical therapy and anti-botulinum toxin antibody on the efficacy of botulinum toxin-A injections in children with spastic cerebral palsy.
Jang DH; Sung IY
Dev Neurorehabil; 2014 Dec; 17(6):414-9. PubMed ID: 25372070
[TBL] [Abstract][Full Text] [Related]
19. Parents' perspectives on the quality of life of adolescents with cerebral palsy: trajectory, choices and hope.
Shikako-Thomas K; Bogossian A; Lach LM; Shevell M; Majnemer A
Disabil Rehabil; 2013; 35(25):2113-22. PubMed ID: 23614371
[TBL] [Abstract][Full Text] [Related]
20. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
Binay Safer V; Ozbudak Demir S; Ozkan E; Demircioglu Guneri F
Neurosciences (Riyadh); 2016 Oct; 21(4):331-337. PubMed ID: 27744462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
